Concepedia

The safety and tolerability of an HIV-1 DNA prime–protein boost vaccine (DP6-001) in healthy adult volunteers

Jeffrey S. Kennedy, Mary Dawn T. Co, Sharone Green, Karen Longtine, Jaclyn Longtine, Melissa A. O'Neill, Janice P. Adams, Alan L. Rothman, Yu Qiao, Renita Johnson-Leva,

Vaccine · 2008 · 58 citations · 27 references

DOIFull text

Open access

Concepts

References

27

Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization

J. M. Orgogozo, S. Gilman, Jean‐François Dartigues et al. · Neurology · 2003 · 1.3K citations

, , +17

Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies

Barton F. Haynes, J. T. Fleming, E. William St. Clair et al. · Science · 2005 · 747 citations · Full text

, , +17

Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies

Alexandra Trkola, Herbert Kuster, Peter Rusert et al. · Nature Medicine · 2005 · 506 citations

, , +14

On the Mechanism of Thrombocytopenic Purpura in Sexually Active Homosexual Men

Christina Walsh, Michael Nardi, Simon Karpatkin · New England Journal of Medicine · 1984 · 306 citations

, , +11

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses

Alexandre Harari, Pierre‐Alexandre Bart, Wolfgang Stöhr et al. · The Journal of Experimental Medicine · 2008 · 294 citations · Full text

, , +17